Clinical Trials Browser

Phase 3 × Tyrosine Kinase Inhibitors × 1 year × Clear all

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Phase 3 Recruiting

Asymptomatic Brain Metastases